Get the Stockscreener App
0.1762
3.40%
+0.0058
ReShape Lifesciences Inc. Stock (RSLS) Forecast
The ReShape Lifesciences Inc. (RSLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $16.29, representing a +9,143% increase from the current price of $0.1762. The highest analyst price target is $27.54, and the lowest is $5.0369.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RSLS Price Target
Average 41.30
(+23,341% Upside)
Is ReShape Lifesciences Inc. (RSLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.12 | Neutral |
| STOCH(9,6) | 43.28 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.000476 | Buy |
| ADX(14) | 25.38 | Buy |
| William %R | -76.93 | Neutral |
| CCI(14) | 372.43 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.1706
Buy
|
0.171
Buy
|
| MA20 |
0.17
Buy
|
0.1702
Buy
|
| MA50 |
0.1705
Buy
|
0.1752
Buy
|
| MA100 |
0.1879
Sell
|
0.2489
Sell
|
| MA200 |
0.366
Sell
|
0.7969
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, RSLS could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 5 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on RSLS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.12 indicates that RSLS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 43.28 indicates that RSLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that RSLS is oversold. This suggests that RSLS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.38 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 372.43 indicates that RSLS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term RSLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about ReShape Lifesciences Inc. financial reports and earnings history, ReShape Lifesciences Inc. (RSLS) stock could reach $63.83 by 2030, $782.50 by 2040 and $1,126.90 by 2050. See the projected annual prices until 2050 of the ReShape Lifesciences Inc. stock below:
- ReShape Lifesciences Inc. (RSLS) is expected to reach an average price of $357.16 in 2035, with a high prediction of $367.09 and a low estimate of $357.62. This indicates an $202.60K% rise from the last recorded price of $0.1762.
- ReShape Lifesciences Inc. (RSLS) stock is projected to chart a bullish course in 2040, with an average price target of $794.00, representing an $450.52K% surge from its current level. The forecast ranges from a conservative $5.5114 to a sky-high $782.50.
- Our analysts predict ReShape Lifesciences Inc. (RSLS) to jump 256.33K% by 2045, soaring from $452.24 to an average price of $451.83, potentially reaching $470.70. While $452.24 is the low estimate, the potential upside is significant.
- ReShape Lifesciences Inc. (RSLS) stock is expected to climb by 2050, reaching an average of $1,107.78, a $628.61K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,126.90 and $1,111.78, respectively, highlighting the market's uncertainty.
ReShape Lifesciences Inc. Stock (RSLS) Year by Year Forecast
ReShape Lifesciences Inc. Stock (RSLS) Price Forecast for 2024
Our forecast for RSLS stock price in 2024 now indicates an average price target of $35.27 with a high forecast of $70.41 and a low forecast of $0.1414. The average prediction reflects an increase of +19,919% from the last recorded price of $0.1762.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $8.5607 | $5.0369 | $27.54 | +4,758% |
| July, 2024 | $9.2233 | $10.72 | $19.34 | +5,135% |
| August, 2024 | $42.85 | $11.79 | $27.10 | +24,221% |
| September, 2024 | $28.98 | $47.92 | $40.95 | +16,349% |
| October, 2024 | $55.65 | $42.55 | $53.40 | +31,481% |
| November, 2024 | $71.28 | $66.18 | $67.74 | +40,352% |
| December, 2024 | $72.41 | $69.34 | $70.41 | +40,993% |
ReShape Lifesciences Inc. Stock (RSLS) Price Forecast for 2025
ReShape Lifesciences Inc. Stock (RSLS) is expected to reach an average price of $69.87 in 2025, with a high prediction of $77.57 and a low estimate of $62.17. This indicates an +39,553% rise from the last recorded price of $0.1762.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $63.07 | $63.57 | $72.97 | +35,694% |
| February, 2025 | $70.30 | $62.17 | $61.60 | +39,797% |
| March, 2025 | $73.53 | $76.33 | $75.66 | +41,630% |
| April, 2025 | $76.55 | $70.07 | $71.61 | +43,346% |
| May, 2025 | $76.62 | $77.52 | $77.57 | +43,386% |
| June, 2025 | $76.63 | $76.19 | $74.15 | +43,391% |
| July, 2025 | $77.86 | $78.38 | $76.41 | +44,091% |
| August, 2025 | $78.03 | $76.73 | $75.54 | +44,185% |
| September, 2025 | $73.85 | $74.87 | $74.14 | +41,815% |
| October, 2025 | $76.79 | $73.63 | $72.80 | +43,480% |
| November, 2025 | $73.97 | $73.97 | $73.92 | +41,879% |
| December, 2025 | $67.95 | $68.52 | $72.22 | +38,464% |
ReShape Lifesciences Inc. Stock (RSLS) Price Forecast for 2026
The predicted value for ReShape Lifesciences Inc. (RSLS) in 2026 is set at an average of $45.67. Estimates vary from a peak of $66.25 to a trough of $25.09, indicating an +25,821% surge from the present price of $0.1762.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $66.74 | $66.67 | $66.25 | +37,777% |
| February, 2026 | $63.42 | $63.84 | $65.29 | +35,893% |
| March, 2026 | $61.45 | $61.52 | $62.63 | +34,775% |
| April, 2026 | $56.80 | $56.88 | $60.07 | +32,138% |
| May, 2026 | $52.89 | $52.91 | $55.42 | +29,919% |
| June, 2026 | $49.76 | $49.79 | $51.80 | +28,142% |
| July, 2026 | $45.18 | $45.28 | $48.67 | +25,539% |
| August, 2026 | $41.53 | $41.68 | $44.18 | +23,470% |
| September, 2026 | $37.15 | $37.19 | $40.55 | +20,986% |
| October, 2026 | $33.73 | $33.78 | $36.15 | +19,041% |
| November, 2026 | $29.91 | $29.93 | $32.73 | +16,873% |
| December, 2026 | $25.09 | $25.09 | $28.92 | +14,139% |
ReShape Lifesciences Inc. Stock (RSLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for ReShape Lifesciences Inc. (RSLS) is $94.67, with a high forecast of $188.36 and a low forecast of $0.9742. This indicates an +53,626% increase from the last price of $0.1762.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.20 | $21.21 | $24.06 | +11,933% |
| February, 2027 | $17.38 | $17.38 | $20.21 | +9,761% |
| March, 2027 | $12.59 | $12.59 | $16.40 | +7,045% |
| April, 2027 | $8.7116 | $8.7128 | $11.60 | +4,844% |
| May, 2027 | $4.8395 | $4.8441 | $7.7155 | +2,647% |
| June, 2027 | $158.67 | $0.9742 | $147.17 | +89,949% |
| July, 2027 | $147.93 | $149.36 | $134.30 | +83,854% |
| August, 2027 | $158.19 | $160.49 | $152.37 | +89,677% |
| September, 2027 | $156.51 | $157.95 | $150.75 | +88,726% |
| October, 2027 | $183.77 | $157.08 | $180.77 | +104.20K% |
| November, 2027 | $177.53 | $184.03 | $181.40 | +100.66K% |
| December, 2027 | $199.86 | $180.10 | $188.36 | +113.33K% |
ReShape Lifesciences Inc. Stock (RSLS) Price Forecast for 2028
In 2028, ReShape Lifesciences Inc. (RSLS) is projected to reach an average price of $179.65, with a high projection of $199.49 and a low estimate of $159.81. This indicates an +101.86K% rise from the last price of $0.1762.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $199.12 | $203.12 | $199.49 | +112.91K% |
| February, 2028 | $199.88 | $198.18 | $197.38 | +113.34K% |
| March, 2028 | $185.20 | $185.64 | $197.94 | +105.01K% |
| April, 2028 | $191.71 | $181.33 | $186.90 | +108.70K% |
| May, 2028 | $174.26 | $185.32 | $190.96 | +98,801% |
| June, 2028 | $186.12 | $181.50 | $183.56 | +105.53K% |
| July, 2028 | $181.63 | $182.25 | $184.16 | +102.98K% |
| August, 2028 | $178.59 | $178.88 | $176.75 | +101.26K% |
| September, 2028 | $172.39 | $173.39 | $175.26 | +97,740% |
| October, 2028 | $169.07 | $170.15 | $168.83 | +95,853% |
| November, 2028 | $160.48 | $160.87 | $165.17 | +90,978% |
| December, 2028 | $158.97 | $159.81 | $158.11 | +90,124% |
ReShape Lifesciences Inc. Stock (RSLS) Price Forecast for 2029
The 2029 price forecast for ReShape Lifesciences Inc. Stock (RSLS) is $111.11 on average, with a high prediction of $156.30 and a low estimate of $65.92. This represents an +62,961% increase from the previous price of $0.1762.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $150.32 | $151.56 | $156.30 | +85,215% |
| February, 2029 | $141.46 | $141.96 | $144.08 | +80,181% |
| March, 2029 | $136.59 | $137.76 | $139.25 | +77,417% |
| April, 2029 | $130.50 | $130.65 | $134.26 | +73,961% |
| May, 2029 | $121.47 | $121.60 | $128.58 | +68,839% |
| June, 2029 | $114.05 | $114.11 | $118.14 | +64,628% |
| July, 2029 | $106.17 | $106.32 | $111.83 | +60,156% |
| August, 2029 | $97.58 | $97.66 | $104.17 | +55,278% |
| September, 2029 | $89.86 | $89.88 | $95.42 | +50,897% |
| October, 2029 | $80.67 | $80.68 | $87.83 | +45,684% |
| November, 2029 | $73.27 | $73.29 | $78.71 | +41,484% |
| December, 2029 | $65.91 | $65.92 | $71.28 | +37,304% |
ReShape Lifesciences Inc. Stock (RSLS) Price Forecast for 2030
ReShape Lifesciences Inc. Stock (RSLS) is expected to reach an average price of $162.63 in 2030, with a high forecast of $323.16 and a low forecast of $2.1085. This signifies an +92,200% surge from the last price of $0.1762.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $56.21 | $56.23 | $63.83 | +31,800% |
| February, 2030 | $48.46 | $48.49 | $54.26 | +27,402% |
| March, 2030 | $40.74 | $40.75 | $46.18 | +23,022% |
| April, 2030 | $33.02 | $33.02 | $38.73 | +18,639% |
| May, 2030 | $23.38 | $23.41 | $31.08 | +13,172% |
| June, 2030 | $15.63 | $15.65 | $21.44 | +8,770% |
| July, 2030 | $5.9687 | $5.9734 | $13.68 | +3,287% |
| August, 2030 | $317.10 | $2.1085 | $306.00 | +179.86K% |
| September, 2030 | $313.49 | $304.89 | $297.49 | +177.82K% |
| October, 2030 | $290.97 | $316.18 | $304.43 | +165.04K% |
| November, 2030 | $299.86 | $302.36 | $293.86 | +170.08K% |
| December, 2030 | $329.76 | $315.96 | $323.16 | +187.05K% |
0.75%
0.85%
Cap:
|
Volume (24h):